Neuroimaging of Adolescent Cannabis Use Treatment
Public ClinicalTrials.gov record NCT07340554. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neuroimaging of Instrumental Learning Networks in Adolescent Cannabis Use Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is testing whether brain activity related to learning can help predict how well teens respond to a treatment program designed to reduce cannabis use. Teens ages 14-17 will complete a brain scan and then take part in 10 weekly virtual sessions where they report cannabis use and complete drug tests at home. Participants can earn prizes for staying cannabis-free.
Study identification
- NCT ID
- NCT07340554
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 80 participants
Conditions and interventions
Conditions
- Cannabis Use
- Cannabis Dependence
- Cannabis Use Disorder
- Cannabis Abuse
- Cannabis Intoxication
- Cannabis Smoking
- Cannabis Withdrawal
- Cannabis-Related Disorder
- Cannabis Abuse, in Remission
- Cannabis Abuse, Episodic Use
- Marijuana
- Marijuana Abuse
- Marijuana Use
- Marijuana Smoking
- Marijuana Dependence
- Marijuana User
- Marijuana-Related Disorder
- Marijuana Use Disorder
- Addiction
- Addiction, Substance
- Substance Use
- Substance Use Disorders
- Substance Dependence
- Substance Abuse
- Substance Related Problem
- Substance Abuse Drug Chronic
Eligibility (public fields only)
- Age range
- 14 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2026
- Primary completion
- Apr 30, 2030
- Completion
- Apr 30, 2030
- Last update posted
- Jun 21, 2026
2026 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University School of Medicine | Indianapolis | Indiana | 46202 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07340554, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07340554 live on ClinicalTrials.gov.